Literature DB >> 10360664

Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival.

M Gentile1, K Olsen, M Dufmats, S Wingren.   

Abstract

Previous studies have demonstrated that the pathological features of breast cancer are more aggressive in younger women than in their older counterparts, and that young age may be an independent marker for adverse prognosis. These findings have raised the question whether these differences are also present at the molecular level. In order to characterize the genetic alterations associated with early-onset breast cancer, 102 cases selected for age under 37 at diagnosis were examined for loss of heterozygosity (LOH) at nine different loci on chromosomes 11, 13 and 17. Ninety cases (88%), exhibited LOH for at least one marker. The D17S855 marker, intragenic in the BRCA1 gene, showed a high proportion of LOH (63%), whereas the intragenic marker for the TP53 gene, HP53, exhibited LOH in 43% of the cases. On chromosome 11, frequencies of LOH peaked at the D11S969 and D11S387 markers, which expressed LOH in 53% and 48% of the informative cases, whereas D11S1818, which is proximate to the ATM gene, exhibited an LOH frequency of 24%. A statistically significant correlation was found between LOH at the D11S387 marker and poor survival (P = 0.028). No such correlation was found for the adjacent D11S969 marker, located approximately 500 kb centromeric to D11S387. We conclude that one or more as yet unidentified genes, situated in chromosome bands 11q24.1-q25, could be involved in the initiation and/or progression of breast cancer in younger women.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360664      PMCID: PMC2362276          DOI: 10.1038/sj.bjc.6690430

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  60 in total

1.  Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene.

Authors:  K K Sanford; R Parshad; F M Price; G M Jones; R E Tarone; L Eierman; P Hale; T A Waldmann
Journal:  J Natl Cancer Inst       Date:  1990-06-20       Impact factor: 13.506

2.  Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction.

Authors:  D Shibata; R K Brynes; B Nathwani; S Kwok; J Sninsky; N Arnheim
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

Authors:  G Bevilacqua; M E Sobel; L A Liotta; P S Steeg
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

4.  Mutations in the p53 gene occur in diverse human tumour types.

Authors:  J M Nigro; S J Baker; A C Preisinger; J M Jessup; R Hostetter; K Cleary; S H Bigner; N Davidson; S Baylin; P Devilee
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

5.  Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.

Authors:  P Devilee; M van Vliet; A Bardoel; T Kievits; N Kuipers-Dijkshoorn; P L Pearson; C J Cornelisse
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

6.  Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Authors:  R S Cornelis; M van Vliet; C B Vos; A M Cleton-Jansen; M J van de Vijver; J L Peterse; P M Khan; A L Børresen; C J Cornelisse; P Devilee
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

7.  The relation between survival and age at diagnosis in breast cancer.

Authors:  H O Adami; B Malker; L Holmberg; I Persson; B Stone
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis.

Authors:  C Hennessy; J A Henry; F E May; B R Westley; B Angus; T W Lennard
Journal:  J Natl Cancer Inst       Date:  1991-02-20       Impact factor: 13.506

10.  Breast and other cancers in families with ataxia-telangiectasia.

Authors:  M Swift; P J Reitnauer; D Morrell; C L Chase
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

View more
  4 in total

1.  Frequent loss of the BLID gene in early-onset breast cancer.

Authors:  L R Cavalli; A-M Noone; K H Makambi; J D Rone; U N Kasid; B R Haddad
Journal:  Cytogenet Genome Res       Date:  2011-08-12       Impact factor: 1.636

2.  Aberrant BLID expression is associated with breast cancer progression.

Authors:  Xiaoyan Li; Peng Su; Xianqiang Liu; Xiangnan Kong; Xin Zhang; Hongyu Zhang; Qifeng Yang
Journal:  Tumour Biol       Date:  2014-02-15

3.  Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.

Authors:  A Baeyens; H Thierens; K Claes; B Poppe; L Messiaen; L De Ridder; A Vral
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

4.  BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway.

Authors:  X Li; X Kong; Y Wang; Q Yang
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.